-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Cytarabine-d2
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/40632-26-62d.gif)
| Category | Herpes simplex Virus (HSV) |
| CAS | 40632-26-6 |
| Description | Cytarabine-[d2] is the labelled analogue of Cytarabine, which could be used as an antineoplastic as well as an antiviral agent. |
Product Information
| Synonyms | Cytarabine-d2;Cytarabine-5,6-d2;40632-26-6;2(1H)-Pyrimidinone-5,6-d2, 4-amino-1-ss-D-arabinofuranosyl- (9CI); Cytosine-5,6-d2-1-ss-D-arabinofuranoside; Cytarabine-d2; 4-Amino-1-ss-D-arabinofuranosyl-2(1H)-pyrimidinone-5,6-d2; Cytarabine-5,6-D2;HY-13605S;MS-23467;CS-0255654;F90692; |
| IUPAC Name | 5,6-dideuterio-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-iminopyrimidin-2-one |
| Molecular Weight | 245.23 |
| Molecular Formula | C9H11D2N3O5 |
| Canonical SMILES | O[C@@H]1[C@@](N2C(N=C(C([2H])=C2[2H])N)=O)([H])O[C@@H]([C@H]1O)CO |
| InChI | InChI=1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7+,8-/m1/s1/i1D,2D |
| InChIKey | UHDGCWIWMRVCDJ-RPTLDJJYSA-N |
| Purity | 98% by HPLC; 98% atom D |
| Solubility | Soluble in DMSO (Slightly, Heated), Ethanol (Slightly), Methanol (Slightly, Heated), Water |
| Appearance | Solid |
| Storage | Store at -20°C |
